SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2026-01-29 14:16
Tx date 2026-01-28
$NTLX
NeuroThera Labs Inc.
Zuloff-Shani, Adi
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+600,000 vol
600,000
Filed 2026-01-29 14:15
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Zuloff-Shani, Adi
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:55
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
Adler, Oz
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+600,000 vol
600,000
Filed 2026-01-11 19:55
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Adler, Oz
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:46
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+400,000 vol
400,000
Filed 2026-01-11 19:45
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:45
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
David, Ohad
4 - Director of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+150,000 vol
150,000
Filed 2026-01-11 19:44
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
David, Ohad
4 - Director of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:43
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
Dayan, Alon
4 - Director of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+150,000 vol
150,000
Filed 2026-01-11 19:42
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Dayan, Alon
4 - Director of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:41
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
VIDER, LIOR
4 - Director of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+150,000 vol
150,000
Filed 2026-01-11 19:40
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
VIDER, LIOR
4 - Director of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-11 19:38
Tx date 2026-01-08
$NTLX
NeuroThera Labs Inc.
Kabazo, Gabi
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
56 - Grant of rights

+600,000 vol
600,000
Filed 2026-01-11 19:36
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Kabazo, Gabi
5 - Senior Officer of Issuer
Direct Ownership
Rights RSU
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-02 07:30
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
contingent rights
00 - Opening Balance-Initial SEDI Report
48,000,000
Filed 2025-11-02 07:29
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
4,000,000
Filed 2025-10-30 22:07
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
D'Silva, Jason Dominic
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options
$16,665
+166,650 vol
$0.10 each
1,066,650
Filed 2025-10-30 22:06
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
D'Silva, Jason Dominic
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options Incentive stock options
51 - Exercise of options
$-16,665
-166,650 vol
$0.10 each
0
Filed 2025-10-24 14:15
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
SciSparc Ltd.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
63,300,000
Filed 2025-10-24 13:55
Tx date 2025-10-22
$NTLX
NeuroThera Labs Inc.
Shrem, Itschak
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
600,000